# HU007 in Patients with Dry Eye Syndrome

> **NCT05743764** · PHASE3 · COMPLETED · sponsor: **Huons Co., Ltd.** · enrollment: 328 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** HU007
- **DRUG:** Restasis
- **DRUG:** Moisview Eye drop

## Key facts

- **NCT ID:** NCT05743764
- **Lead sponsor:** Huons Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-23
- **Primary completion:** 2024-02-14
- **Final completion:** 2024-02-14
- **Target enrollment:** 328 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05743764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05743764, "HU007 in Patients with Dry Eye Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05743764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*